|
°£È£»ç´Â ȯÀÚ, µ¿·á ±×¸®°í ÀÚ½ÅÀ» º¸È£Çϱâ À§ÇØ º¸°Ç ÀÇ·á ȯ°æ¿¡¼ÀÇ ¶óÅØ½º À§Çè¿¡ ´ëÇØ ¾Ë¾Æ¾ß ÇÑ´Ù. 1979³â Nutter¿¡ ÀÇÇØ óÀ½À¸·Î ¶óÅØ½º¿¡ ´ëÇÑ °ú¹Î¹ÝÀÀÀÌ º¸°íµÈ ÀÌÈÄ·Î ¿©·¯ Á÷¾÷±º¿¡¼ ¶óÅØ½º ¾Ë·¹¸£±â ¹ÝÀÀÀÇ »ç·Ê°¡ º¸°íµÇ¾ú´Ù. 1980³â´ë ÈÄ¹Ý ÀÌ·¡·Î, AIDSµî ÁúȯÀÇ ÀÏÁ¾ÀÇ ¹æ¾î¹°·Î¼ ¶óÅØ½º Àå°©¿¡ ´ëÇÑ »ç¿ëÀÌ ±Þ°ÝÈ÷ Áõ°¡ÇÏ¿© ¶óÅØ½º Á¦Ç°¿¡ Æ÷ÇԵǾî ÀÖ´Â ´Ü¹éÁú¿¡ ´ëÇÑ ¾Ë·¹¸£±â´Â Á¡Â÷ Å« ¹®Á¦°¡ µÇ°í ÀÖ´Ù ¹Ì±¹ÀÇ °æ¿ì, 1988³âºÎÅÍ 1992³â »çÀÌ¿¡ °ËÁø¿ë Àå°© »ç¿ëÀÌ 118¾ï°³, ¿Ü°ú¿ë ¶óÅØ½º, ¶óÅØ½º Àå°© »ç¿ëÀÌ 18¾ï°³·Î ÃßÁ¤µÇ°í ÀÖ´Ù(Sussman & Beezhold, 1995).
¶óÅØ½º ¾Ë·¹¸£±â¿¡ ÀÇÇÑ Áõ»óÀº ÇǺο°, ¹ßÁø, ºñÃæÇ÷(nasal congestion) µî¿¡¼ õ½Ä, À½½Ä °ü·Ã¹ÝÀÀ(food cross reaction), ¾Æ³ªÇʶô½Ã½º ¹ÝÀÀÀÇ Àü½ÅÀû Áõ»ó¿¡ À̸£±â±îÁö ´Ù¾çÇϸç, ½ÉÁö¾î »ç¸ÁÇÑ °æ¿ìµµ º¸°íµÇ°í ÀÖ´Ù(Tomazic, Withrow, Fisher & Dillard, 1992). Ãʱ⿡´Â °í¹« Á¦Ç°¿¡ ÀÇÇÑ ºÎÀÛ¿ëÀ¸·Î Áö¿¬Çü °ú¹Î¹ÝÀÀ¿¡ ´ëÇÑ ¹®ÇåÀÌ ´ëºÎºÐÀ̾úÁö¸¸, ÇǺΠ¹× Àü½ÅÀû °ú¹Î¹ÝÀÀÀ» ¾ß±âÇÔ¿¡ ´ëÇѺ¸°í°¡ Áõ°¡ÇÏ¸é¼ Ig-E¸Å°³¼º °ú¹Î¹ÝÀÀÀÌ Áß¿ë½ÃµÇ°í ÀÖ´Ù. ÀÌ¿Í °°Àº ¶óÅØ½º ¾Ë·¹¸£±â ÀÓ»ó»óÀº Ç׿øÀÇ ¾ç°ú ³ëÃâÇü Å¿¡ ÀÇÁ¸ÀûÀÌ´Ù. °¡´ÉÇÑ ³ëÃâÇü Å´ Çdz»(cutaneous), Á¡¸·(mucous membrane), ÈíÀÔ(inhalation), ³»ºÎ Á¶Á÷(infernal tissue), Ç÷°ü³»(intravascular)°¡ µÈ´Ù. ½É°¢ÇÑ ºÎÀÛ¿ëÀÇ ´ëºÎºÐÀº ÀÔÁú, Á÷ÀåÀÇ Á¡¸· Á¢ÃËÀ¸·Î ÀÎÇÑ °ÍÀ̾ú´Ù (Axelsson, Johansson & Wransjo, 1987). ȯÀÚ¿Í º¸°Ç ÀÇ·á Á¦°øÀÚµéÀº ¹Ýº¹ÀûÀÎ ÇǺγª Á¡¸·ÀÇ Á¢ÃË, ¶Ç´Â ¿¡¾î·ÎÁ¹ ÇüÅÂÀÇ Àå°© ¾Ë·¯Á¨À» ÈíÀÔÇÔÀ¸·Î¼ ¶óÅØ½º¿¡ °¨À۵ȴÙ. ¶óÅØ½º¿¡ ´ëÇÑ °è¼ÓÀûÀÎ ³ëÃâÀº °¨ÀÛ(sensitiaztion)À» Áõ°¡½ÃŰ°í ¾Ë·¹¸£±â ¹ÝÀÀÀ» ¾ÇȽÃŰ°Ô µÈ´Ù. ƯÈ÷ Àå°©ÀÇ °æ¿ì ´Ù¸¥ ¶óÅØ½º Á¦Ç°¿¡ ºñÇØ ¶óÅØ½º ´Ü¹éÁú ÇÔ·®ÀÌ ³ôÀº °ÍÀ¸·Î º¸°íµÇ¾î(Tomazic µî, 1992), Á÷¾÷»ó ¶óÅØ½º Àå°©À» ¼ö½Ã·Î »ç¿ëÇØ¾ß ÇÏ´Â °æ¿ì ÀϹÝÀκ¸´Ù(1%¹Ì¸¸) ÀÇ·áÀÎÀÇ °æ¿ì ¶óÅØ½º ¾Ë·¹¸£±â ¹ß»ýºóµµ°¡ ÈξÀ ³ô´Ù(furianmaa & Reunala, 1988). Turjanmaa(1987)´Â ¼ö¼úÀå °£È£»ç, 5.6-12.5% ¿Ü°ú ÀÇ»ç, 6.6-7.4% ´Ù¸¥ ºÎ¼ÀÇ ÀÇ·áÀÎÀÎ °æ¿ì 2.9%ÀÇ ¹ß»ý·üÀ» º¸°íÇÏ¿´
´Ù. ¶ÇÇÑ Àå°© Âø¿ëÀÇ À±È°Á¦·Î¼ »ç¿ëµÇ´Â ÀüºÐ°¡·çÀÇ °æ¿ì ¶óÅØ½º Àå°©À¸·ÎºÎÅÍ ´Ü¹éÁú ¾Ë·¯Á¨À» Èí¼öÇϰí, ÇǺγª Á¡¸·, ¼ö¼ú »óó·Î ¿î¹ÝÇϸç, ¿¡¾î·ÎÁ¹ ¾Ë·¯Á¨À¸·Î ¸¸µé±âµµ ÇÑ´Ù. °á±¹ ¶óÅØ½º ¾Ë·¹¸£±âÀÎ ¸¹Àº »ç¶÷µé¿¡°Ô Áõ»óÀ» À¯¹ß½ÃŰ°Ô µÇ´Â °ÍÀÌ´Ù.
¶óÅØ½º ¾Ë·¹¸£±â¿¡ ´ëÇÑ ±Ùº»ÀûÀÎ ´ëÃ¥Àº ¶óÅØ½º¿¡ ´ëÇÑ ³ëÃâÀ» ÇÇÇÏ´Â °ÍÀÌ´Ù. ±×·¯³ª ½ÇÁ¦ÀûÀ¸·Î ºÒ°¡´ÉÇÏ¿© ¿©·¯°¡Áö Àú¾Ë·¹¸£±â¼º Àå°©À» »ç¿ëÇϳª ±× Áß ÀϺθ¸ÀÌ È¿´ÉÀÌ ÀÖ´Â °ÍÀ¸·Î º¸°íµÇ°í ÀÖ´Ù(ȲÁöÀÎ, 1997).
|
Immdeiate hypersensitivity reactions to natural rubber and latex products pose a significant threat to patients, healthcare workers, and the general population. The purpose of this study is to summarize the clinical syomptoms of latex rubber
allergy and provide guidelines for the management of latex allergy. Contact dermatitis from the nearly constant use of latex gloves during the workday has become a real problem for many health care professionals. Moreover, the patient
who come in contact with these gloves or with other latex-containing equipment may show reactors. Far worse than skin problems is life-threatening anaphyaxis, which can be the first indication that a person has latex sensitivity.
In conclusion, nurses scold know the latex precautions such as risk factors, adverse reactons to latex, emergent treatment and so on.
|